REGISTRATION

30min

LECTURE SESSION 2: Epilepsy

Chairs: Paul Boon + outside Ghent

• 8:45-9:15 am: How can neuroimaging aid the clinician? Alfred Meurs (Belgium)
• 9:15-9:45 am: Nuclear medicine to find the culprit. Alexander Hammers (The UK)
• 9:45-10:15 am: Novel MRI techniques to find the culprit. Catherine Oppenheim (France)

90min

COFFEE BREAK

15min

ORAL COMMUNICATION 2: Movement disorders and traumatic brain injuries

• 10:30-10:40 am: Multimodal Neuroimaging Assessment of MMAE for CSDH on the Integrity of Subjacent Brain, Alejandra Mosteiro
• 10:40-10:50 am: Reference Region Normalization Outperforms Data-Driven Approaches in [¹⁸F]FDG PET of Dementia with Lewy Bodies, Antoine Rogeau
• 10:50-11:00 am: Persistent Male Cholinergic Vulnerability in De Novo Parkinson’s Disease: Longitudinal Insights from Clinical and Cholinergic Molecular Imaging, Eline De Meyer
• 11:00-11:10 am: PET imaging of presynaptic protein SV2A with [11C]UCB-J and [18F]SynVesT-1: a head-to-head comparison in people with Huntington’s disease and controls, Jolien Van Opstal
• 11:10-11:20 am: Imaging of presynaptic terminals with [18F]SynVesT-1 PET in premanifest Huntington's disease, Jolien Van Opstal
• 11:20-11:30 am: Clinical Utility of [¹²³I]Ioflupane (DATSCAN) in Guiding Dopaminergic Therapy for Parkinsonism, José Pedro Escaleira
• 11:30-11:40 am: Cognitive impairment in individuals with chronic spinal cord injury: a Flanker task-based functional magnetic resonance imaging study, Jothini Sritharan
• 11:40-11:50 am: Initial evaluation of 18F-AV133 imaging on the ultra-high performance United Imaging NeuroEXPLORER PET/CT brain scanner for Parkinson’s Disease
• 11:50 am-12:00 pm: Parametric imaging of [18F]PE2I uptake in the substantia nigra pars compacta is feasible with ultra-high performance NeuroEXPLORER PET, Louis Versweyveld
• 12:00-12:10 pm: Parietal Regional Homogeneity Predicts Recovery Outcomes in Older Patients with Mild Traumatic Brain Injury, Yadong Liu

100min

LUNCH

60min

LECTURE SESSION 3: Technical innovations in nuclear medicine

Chairs: Donatienne Van Weehaeghe + outside Ghent

• 1:00-1:30 pm: Ultra-high resolution brain PET imaging with the NeuroEXPLORER in a research and clinical context. Koen Van Laere (Belgium)
• 1:30-2:00 pm:  Whole body PET. Stefaan Vandenberghe (Belgium)
• 2:00-2:30 pm: Artificial intelligence. Irène Buvat (France)

90min

SATELLITE SYMPOSIUM 2

30min

COFFEE BREAK

15min

ORAL COMMUNICATION 3: Novel techniques and neuroimaging go hand in hand

• 3:25-3:35 pm: Effects of a Deep Learning-Based Noise Reduction Algorithm on Visual Analysis and Centiloid Quantification in Amyloid PET Imaging with a Reduced Dose, Antoine Verger
• 3:35-3:45 pm:  [18F]-Flutemetamol across acquisition timeframes:  Clinical Interpretability Combining Visual Read and Centiloids
• 3:45-3:55 pm:  Effects of motion and white matter hyperintensities on reference-region ¹⁸F-SynVesT-1 quantification in Alzheimer’s disease and healthy volunteers, Charles Carron
• 3:55-4:05 pm: Age-related alterations in resting-state EEG microstate dynamics across adulthood, Ebru Yildirim
• 4:05-4:15 pm:  Non-invasive measurement of cerebrovascular reactivity using 15O-water PET, Elin Bäck
• 4:15-4:25 pm:  Shortening Vizamyl amyloid PET acquisition time: optimal reconstruction parameters and effect on Centiloids, Emile Balot
• 4:25-4:35 pm:  Simultaneous multiple post-labelling delay ASL MRI and [18F]FDG PET in a mixed memory clinic popu-lation and healthy controls, Otto Mølby Henriksen
• 4:35-4:45 pm:  Statistical Complexity Reveals Internal Learning Dynamics of Deep Neural Networks in Alzheimer’s and MCI MRI Classification, Seyi Olabisi Omotoso
• 4:45-4:55 pm:  Reducing scan time using 18F Florbetaben Amyloid Brain PET imaging with Digital PET-CT Scanners, Teresa Szyszko
• 4:55-5:05 pm:  Differential effects of hypercapnia on cerebral vascular reactivity and glucose metabolism, Vanbutsele Thibault

90min

SATELLITE SYMPOSIUM 3

30min

AWARDS

15min

REGISTRATION

30min

LECTURE SESSION 4: CAA and vasculopathy

Chairs: Veerle De Herdt + Eric Guedj

• 8:45-9:15 am: Short and long term consequences of CAA and vasculopathy. Marco Pasi (France)
• 9:15-9:45 am: MRI in CAA and vasculopathy. Claudia Godi (The UK)
• 9:45-10:15 am: Diagnostic value of amyloid and FDG PET in cerebral amyloid angiopathy. Jean-Claude Baron (France)

90min

COFFEE

15min

ORAL COMMUNICATION 4: Amino-acid and neurotransmitter systems visualized

• 10:30-10:40 am: Spatial correlation between 68Ga-FAPI uptake, 18F-FET uptake, and MRI makers of aggressiveness in glioblastoma, Amélie Castiaux
• 10:40-10:50 am: Amino acid PET imaging to monitor mIDH inhibitor treatments in patients with refractory IDH-mutant gliomas, Antoine Verger
• 10:50-11:00 am: Microvascular physiology in glioma using dynamic [¹⁸F]FET LAFOV PET/CT and Tikhonov model-free deconvolution, Christian Engkebølle
• 11:00-11:10 am: Longitudinal brain metabolism changes map distinct neuromodulatory networks in autoimmune encephalitis, Federico Massa
• 11:10-11:20 am: Quantitative [18F]FET PET for Pituitary Neuroendocrine Tumours (PitNET): A Case-Control Study Comparing Pathologically Confirmed functional PitNETs wi, Ilanah Pruis
• 11:20-11:30 am: Uncovering Hidden Prognostic Phenotypes in Glioblastoma: A Composite-Parameter Radiomic Stratification Framework for Equitable AI, Nicholas Laflamme
• 11:30-11:40 am: In-vivo imaging and quantification of central noradrenaline transporters using [¹¹C]MRB PET/MRI in adults with ADHD and emotional dysregulation, Nicole Mauche
• 11:40-11:50 am: The confounding effects of microvascular physiology on the uptake and diagnostic accuracy of [18F]fluoroethyl-tyrosine positron emission tomography in, Otto Mølby Henriksen
• 11:50am-12:00 pm: Enhancing PitNET Diagnosis: The Role of [18F]FET PET, Valerie De Meulenaere

90min

LUNCH

60min

ORAL COMMUNICATION 5: Neuroimaging potpourri: a bit of everything

• 1:00-1:10 pm:  Can Minimally Invasive Evacuation of Intracerebral Haemorrhage plus Glibenclamide Reduce Secondary Brain Damage? A Murine Model Assessing Blood-Brain, Alejandra Mosteiro
• 1:10-1:20 pm: Understanding the Importance of Blood-Brain Barrier Alterations in Brain Arteriovenous Malformations and Implications for Treatment: A Dynamic Contras, Alejandra Mosteiro
• 1:20-1:30 pm:  PET reconstruction harmonisation using a Hoffman phantom for longitudinal plausibility in an Alzheimer’s study, Boniface Hugo
• 1:30-1:40 pm: Current Trends and Challenges in Clinical Neuroimaging in Cameroon, Ekotto Staecy Brenda
• 1:40-1:50 pm: Brain FDG-PET, guiding treatment in a complex case, Finn Herdewyn
• 1:50-2:00 pm: Frontal meningoencephalocele as a cause of super-refractory status epilepticus: a unique case report, Kato Van Rooy
• 2:00-2:10 pm:  Feasibility of Transcranial Ultrasound Stimulation (TUS) to the M1 hand area with MRI-guided targeting and a flexible water-balloon coupling system, Lara Hogeveen
• 2:10-2:20 pm: Unsupervised clustering for non-invasive TSPO PET imaging of neuroinflammation, Marina Rodriguez Rodriguez
• 2:20-2:30 pm: First clinical experiences with the ultra-fast time-of-flight BIOGRAPH One next generation hybrid PET/MRI system, Otto Mølby Henriksen
• 2:30-2:40 pm: Spinal Muscular Atrophy neurophysiology assessment in Patients Identified by Newborn Screening, Paola Lanteri
• 2:40-2:50 pm: Effects of Voxel Size, VOI Dimensions, and PSF Correction on PET IDIF Accuracy in a Carotid Phantom as Measured with the NeuroExplorer, Valentina Turmacu

110mn

CONCLUSION

30min